<SEC-DOCUMENT>0001213900-23-061038.txt : 20230731
<SEC-HEADER>0001213900-23-061038.hdr.sgml : 20230731
<ACCEPTANCE-DATETIME>20230731093040
ACCESSION NUMBER:		0001213900-23-061038
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230731
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230731
DATE AS OF CHANGE:		20230731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABVC BIOPHARMA, INC.
		CENTRAL INDEX KEY:			0001173313
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				260014658
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40700
		FILM NUMBER:		231125304

	BUSINESS ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-668-0881

	MAIL ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	American BriVision (Holding) Corp
		DATE OF NAME CHANGE:	20160111

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METU BRANDS, INC.
		DATE OF NAME CHANGE:	20150908

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ECOLOGY COATINGS, INC.
		DATE OF NAME CHANGE:	20080821
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea182578-8k_abvcbio.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ABVC="http://abvcpharma.com/20230731">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_ABVC_abvcpharma.com_20230731 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20230731_20230731 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001173313 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityCentralIndexKey">0001173313</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abvc-20230731.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-31</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_903_edei--DocumentType_c20230731__20230731_zIWs57ye3bL5"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_905_edei--DocumentPeriodEndDate_c20230731__20230731_zBAKJgXnzPq9"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 31, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20230731__20230731_zVo66WcfdQng"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityRegistrantName">ABVC BIOPHARMA, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20230731__20230731_zpqHy0POSSsj"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20230731__20230731_zm1jvIAlqKYk"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityFileNumber">333-91436</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20230731__20230731_zVeM6LnYZGO7"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityTaxIdentificationNumber">26-0014658</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction<br />
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer<br />
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span><span id="xdx_90F_edei--EntityAddressAddressLine1_c20230731__20230731_zOYtVz9XkLzk"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityAddressAddressLine1">44370 Old Warm Springs Blvd.</ix:nonNumeric></span></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20230731__20230731_zQlvv2R7mGeh"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityAddressCityOrTown">Fremont</ix:nonNumeric></span>, <span><span id="xdx_903_edei--EntityAddressStateOrProvince_c20230731__20230731_zAmjvfrdz16j"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> </span></b></p></td>
    <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20230731__20230731_zbLHM5el6wV8"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:EntityAddressPostalZipCode">94538</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number including area
code: <b>(<span id="xdx_906_edei--CityAreaCode_c20230731__20230731_zSGQcVyjtURd"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:CityAreaCode">510</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20230731__20230731_z7L8X52KY3qf"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:LocalPhoneNumber">668-0881</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--WrittenCommunications_c20230731__20230731_zaz0KghsChE4"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SolicitingMaterial_c20230731__20230731_zGKr7zqtF8Se"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20230731__20230731_zFUa4q0YE3x5"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20230731__20230731_zHZCoJrIxgvf"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-size: 10pt">Title of Each Class</span></td>
    <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-size: 10pt">Trading Symbol</span></td>
    <td style="vertical-align: top; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20230731__20230731_zXxocnSXmMxe"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20230731__20230731_zLBztBnLp6Ma"><ix:nonNumeric contextRef="AsOf2023-07-31" name="dei:TradingSymbol">ABVC</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span>The <span id="xdx_90D_edei--SecurityExchangeName_c20230731__20230731_zkZPaUNQJiMf"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule
12b&#8211;2 of the Securities Exchange Act of 1934 (&#167; 240.12b&#8211;2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20230731__20230731_zuXMOkJEHvS"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into Material Definitive Agreements</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As disclosed on ABVC BioPharma,
Inc.&#8217;s (the &#8220;<b>Company</b>&#8221;) Current Report on Form 8-K (the &#8220;<b>Form 8-K</b>&#8221;) filed on July 27, 2023,
the Company entered into certain securities purchase agreement, dated July 27, 2023 (the &#8220;<b>SPA</b>&#8221;), with a certain institutional
investor (the &#8220;<b>Purchaser</b>&#8221;). Pursuant to the SPA, the Company agreed to issue 300,000 shares (the &#8220;<b>Shares</b>&#8221;)
of its common stock, par value $0.001 per share (the &#8220;<b>Common Stock</b>&#8221;) <span style="background-color: white">and 200,000
pre-funded warrants, at an exercise price of $0.01 per share (the &#8220;<b>Pre-funded Warrants</b>&#8221;), in a registered direct offering
(the &#8220;<b>Offering</b>&#8221;)</span>. Wilmington Securities LLC <span style="background-color: white">acted as placement agent for
the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transaction contemplated
by the SPA was closed on July 31, 2023, as all the closing conditions have been satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the
terms of the SPA and Pre-funded Warrant is subject to, and qualified in its entirety by, the complete agreements, which are attached as
exhibits to this filing and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sale and offering of the
Shares and Pre-funded Warrants pursuant to the SPA was effected as a takedown off the Company&#8217;s shelf registration statement on
Form S-3, as amended (File No. 333-260588), which became effective on November 29, 2021 (the &#8220;<b>Registration Statement</b>&#8221;).
A final prospectus supplement to the Registration Statement was filed with the Securities and Exchange Commission on July 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay to the placement
agents an aggregate cash fee equal to 6% of the aggregate sales price of the securities sold and warrants to purchase up to 30,000 shares
of Common Stock, on the same terms as the Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This report shall not constitute
an offer to sell or the solicitation to buy nor shall there be any sale of the securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The disclosure provided in
Item 1.01 above is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statement and Exhibits </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023060140/ea182424ex4-1_abvcbio.htm">Form of Pre-Funded Warrants (Incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on July 27, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">5.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea182578ex5-1_abvcbio.htm">Opinion of Hunter Taubman Fischer &amp; Li LLC</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023060140/ea182424ex10-1_abvcbio.htm">Form of Securities Purchase Agreement (Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on July 27, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea182578ex99-1_abvcbio.htm">Press Release dated July 31, 2023</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cover Page Interactive Data File (embedded within
    the Inline XBRL document)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>ABVC BioPharma, Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 36%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">July 31, 2023</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt">/s/ Uttam Patil</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Uttam Patil</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2Wkzt38ukJLIIieh2yymWdEdmt79H6i3blGgYGIZzvnOE8EVGC1Uhw2FW5LDDuqmkRSjwjIz6hM6RLlcJuFvgRRnLUtv2/YEpOQYdMwyi6dEJrfWuDJYJhONePOnFfQgHSX8E27XwvnpK+qxK1FbJCqQuYcvUsEIr+dUl7OSTNNWvtmqPbBTpBKIg7OQ3xGEUw4bu8kF8NZDnqfD8djyRMd2ab83NWKphXmHtukyH/tf7ACJ9SVo= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea182578ex5-1_abvcbio.htm
<DESCRIPTION>OPINION OF HUNTER TAUBMAN FISCHER & LI LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex5-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
31, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
BioPharma, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44370
Old Warm Springs Blvd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fremont,
CA 94538</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:
Registration Statement on Form S-3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
have requested our opinion with respect to the offer, sale and issuance by you, ABVC BioPharma, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
pursuant to a Registration Statement (File No. 333-260588) (the &ldquo;<B>Registration Statement</B>&rdquo;) on Form S-3 under the Securities
Act of 1933, as amended (the &ldquo;<B>Act</B>&rdquo;), of (i)&nbsp;300,000 shares of common stock, par value $0.001 per share, of the
Company (the &ldquo;<B>Common Stock</B>&rdquo;), (ii) pre-funded warrants to purchase up to 200,000 shares of Common Stock (the &ldquo;Pre-Funded
<B>Warrants</B>&rdquo;), (iii) the shares of Common Stock underlying the Warrants, (the &ldquo;<B>Pre-Funded</B> <B>Warrant Shares&rdquo;)</B>,
and (iv) placement agent warrants (the &ldquo;<B>Placement Agent Warrants</B>&rdquo;, together with the Pre-Funded Warrants, collectively
the &ldquo;<B>Warrants</B>&rdquo;) to purchase up to an aggregate of 30,000 shares of Common Stock (the &ldquo;<B>Placement Agent Warrant
Shares</B>,&rdquo; which, collectively with the Common Stock, the Warrants and the Pre-Funded Warrant Shares, are referred to herein
as the &ldquo;<B>Securities</B>&rdquo;), pursuant to the terms of the Engagement Agreement, dated October 12, 2022, as amended on January
30, 2023, between Allele Capital Partners, LLC together with its executing broker dealer, Wilmington Capital Securities, LLC (the &ldquo;<B>Placement
Agent</B>&rdquo;) and the Company (the &ldquo;<B>Engagement Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
rendering the opinions set forth below, we have examined originals or copies certified or otherwise identified to our satisfaction of
such documents and corporate and public records as we deem necessary as a basis for the opinions hereinafter expressed. With respect
to such examination, we have assumed the genuineness of all signatures appearing on all documents presented to us as originals, and the
conformity to the originals of all documents presented to us as conformed or reproduced copies. Where factual matters relevant to such
opinions were not independently established, we have relied upon certificates of executive officers and responsible employees and agents
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this opinion letter, we have also assumed that (a)&nbsp;the Registration Statement, and any amendments thereto (including
post-effective amendments), will have become effective and such effectiveness will not have been terminated or rescinded, (b)&nbsp;a
prospectus supplement will have been prepared and filed with the Securities and Exchange Commission describing the Securities offered
thereby, (c)&nbsp;all Securities will be offered, issued and sold in compliance with applicable federal and state securities laws and
in the manner stated in the Registration Statement and the appropriate prospectus supplement, (d)&nbsp;any definitive purchase, underwriting
or similar agreement with respect to any Securities offered will have been duly authorized and validly executed and delivered by the
Company and the other parties thereto, (e)&nbsp;any securities issuable upon exercise of any Securities being offered will have been
duly authorized, created and, if appropriate, reserved for issuance upon such exercise, (f)&nbsp;at the time of any offering or sale
of any shares of Common Stock, Placement Agent Warrant Shares, Pre-Funded Warrant Shares or Warrants to purchase shares of Common Stock,
there will be sufficient shares of Common Stock authorized and unissued under the Company&rsquo;s then operative articles of incorporation,
as amended (the &ldquo;<B>Articles of Incorporation</B>&rdquo;) and not otherwise reserved for issuance, (g)&nbsp;at the time of issuance
of the Securities, the Company validly exists and is duly qualified and in good standing under the laws of its jurisdiction of incorporation,
and has the necessary corporate power for such issuance, (h)&nbsp;at the time of issuance of the Securities, the Articles of Incorporation
and then operative bylaws of the Company, as amended (the &ldquo;<B>Bylaws</B>&rdquo; and collectively with the Articles of Incorporation,
the &ldquo;<B>Charter Documents</B>&rdquo;) are in full force and effect and have not been amended, restated, supplemented or otherwise
altered, and there has been no authorization of any such amendment, restatement, supplement or other alteration, in either case since
the date hereof, and (i)&nbsp;that the terms, execution and delivery of the Securities (i)&nbsp;do not result in breaches of, or defaults
under, agreements or instruments to which the Company is bound or violations of applicable statutes, rules, regulations or court or governmental
orders, and (ii)&nbsp;comply with any applicable requirement or restriction imposed by any court or governmental body having jurisdiction
over the Company. We have further assumed the legal capacity of natural persons, and we have assumed that each party to the documents
we have examined or relied on has the legal capacity or authority and has satisfied all legal requirements that are applicable to that
party to the extent necessary to make such documents enforceable against that party. We have not verified any of the foregoing assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 8pt Garamond, Times, Serif; margin: 6pt 0 0; text-align: center">www.htflawyers.com | info@htflawyers.com</P>

<P STYLE="font: 8pt Garamond, Times, Serif; margin: 0 0 6pt; text-align: center">950 Third Ave., Floor 19 - New York, NY 10022 | <FONT>Office:</FONT>
(212) 530-2210 | <FONT>Fax:</FONT> (212) 202-6380</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex5-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not express any opinion as to matters arising under the laws of any jurisdiction other than the United States federal securities laws
and Chapter 78 of the Nevada Revised Statutes (&ldquo;<B>NRS</B>&rdquo;) as the same appear on the date hereof at https://www.leg.state.nv.us/nrs/nrs-078.html.
We are not members of the Bar of the State of Nevada and have not obtained any opinions of local counsel. Insofar as the opinions expressed
herein relate to matters of the United States federal securities laws or regulations or matters of the NRS, we have relied exclusively
on the latest standard compilations of such statutes and laws as reproduced in commonly accepted unofficial publications available to
us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon and subject to the foregoing and the other matters set forth herein, it is our opinion that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;With
respect to the shares of Common Stock offered under the Registration Statement, when (a)&nbsp;the Company has taken all necessary action
to authorize and approve the issuance thereof and related matters, and (b)&nbsp;certificates representing the shares of Common Stock
have been duly executed, countersigned, registered and delivered, or if uncertificated, valid book-entry notations have been made in
the share register of the Company, in each case in accordance with the Charter Documents, either (i)&nbsp;against payment therefor in
an amount not less than the par value thereof or such other consideration determined by the Company&rsquo;s Board of Directors and permitted
under the NRS and in the manner contemplated by the Registration Statement and/or the applicable prospectus supplement and in accordance
with the provisions of the applicable definitive purchase, underwriting or similar agreement, if any, approved by the Company or (ii)&nbsp;upon
exercise of any other Security in accordance with the terms of such Security or the instrument governing such Security as approved by
the Company, for the consideration approved by the Company (in an amount not less than the par value thereof or such other consideration
determined by the Company&rsquo;s Board of Directors and permitted under the NRS), the shares of Common Stock will be duly authorized,
validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;With
respect to the Warrants offered under the Registration Statement, when (a)&nbsp;the Company has taken all necessary action to authorize
and approve the creation of and the issuance and terms of the Warrants, the terms of the offering thereof and related matters, (b)&nbsp;&nbsp;the
Warrants have been duly executed and delivered against payment therefor in accordance with the Warrants and
in the manner contemplated by the Registration Statement and/or the applicable prospectus supplement (assuming the securities issuable
upon exercise of the Warrants have been duly authorized and reserved for issuance by all necessary corporate action and in accordance
with applicable law), the Warrants will constitute valid and binding obligations of the Company, enforceable against the Company in accordance
with their terms, except: (a) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting
creditors&rsquo; rights generally and by general equitable principles (regardless of whether enforceability is considered in a proceeding
in equity or at law), including but not limited to principles limiting the availability of specific performance and injunctive relief,
and concepts of materiality, reasonableness, good faith and fair dealing; (b) as enforceability of any indemnification or contribution
provision may be limited under the federal and state securities laws, and (c) that the remedy of specific performance and injunctive
and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
With respect to the Pre-Funded Warrant Shares and Placement Agent Warrant Shares issuable upon exercise of the Pre-Funded Warrants and
Placement Agent Warrants, respectively, when the respective Warrant is exercised in accordance with the terms thereof, the Pre-Funded
Warrant Shares and Placement Agent Warrant Shares, as applicable will be duly authorized, validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
express no opinions regarding (i)&nbsp;the validity or enforceability of any provisions that purport to waive or not give effect to rights
or notices, defenses, subrogation or other rights or benefits that cannot be effectively waived under applicable law, (ii)&nbsp;the enforceability
of indemnification provisions to the extent they purport to relate to liabilities resulting from or based upon negligence or any violation
of federal or state securities or blue sky laws, (iii)&nbsp;any provision for liquidated damages, default interest, late charges, monetary
penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty, (iv)&nbsp;consents
to, or restrictions upon, governing law, jurisdiction, venue, arbitration, remedies or judicial relief, (v)&nbsp;any provision requiring
the payment of attorneys&rsquo; fees, where such payment is contrary to law or public policy, (viii)&nbsp;provisions for exclusivity,
election or cumulation of rights or remedies, (ix)&nbsp;provisions authorizing or validating conclusive or discretionary determinations,
(x)&nbsp;grants of setoff rights, (xi)&nbsp;the availability of equitable remedies to any person or entity including, but not limited
to, specific performance and injunctive relief; (xii)&nbsp;the effect of bankruptcy, reorganization, insolvency, fraudulent conveyance,
fraudulent transfer, moratorium and other similar laws or equitable principles affecting creditors&rsquo; rights or remedies (whether
applied by a court of law or equity), (xiii)&nbsp;the effect of applicable law and court decisions which may hereafter limit or render
unenforceable certain rights or remedies of any person or entity and (xiv)&nbsp;the severability, if invalid, of provisions to the foregoing
effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 8pt Garamond, Times, Serif; margin: 6pt 0 0; text-align: center">www.htflawyers.com | info@htflawyers.com</P>

<P STYLE="font: 8pt Garamond, Times, Serif; margin: 0 0 6pt; text-align: center">950 Third Ave., Floor 19 - New York, NY 10022 | <FONT STYLE="font-family: Times New Roman, Times, Serif">Office:</FONT>
(212) 530-2210 | <FONT>Fax:</FONT> (212) 202-6380</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex5-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the use of this opinion as Exhibit 5.1 to the Registration Statement, and to the use of our name as your counsel under
&ldquo;Legal Matters&rdquo; in the Prospectus constituting a part of the Registration Statement. In giving this consent, we do not thereby
concede that we come within the categories of persons whose consent is required by the Act or the General Rules and Regulations promulgated
thereunder. We assume no obligation to update or supplement any of the opinions set forth herein to reflect any changes of law or fact
that may occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Hunter Taubman Fischer &amp; Li LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hunter
    Taubman Fischer &amp; Li LLC</FONT></P></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 8pt Garamond, Times, Serif; margin: 6pt 0 0; text-align: center">www.htflawyers.com | info@htflawyers.com</P>

<P STYLE="font: 8pt Garamond, Times, Serif; margin: 0 0 6pt; text-align: center">950 Third Ave., Floor 19 - New York, NY 10022 | <FONT>Office:</FONT>
(212) 530-2210 | <FONT>Fax:</FONT> (212) 202-6380</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ea182578ex99-1_abvcbio.htm
<DESCRIPTION>PRESS RELEASE DATED JULY 31, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ABVC BioPharma Announces Closing on $1.75
Million Registered Direct Offering</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Fremont, CA (July
31, 2023) </B>&ndash; ABVC BioPharma, Inc. (NASDAQ: ABVC) (&ldquo;Company&rdquo;), a clinical-stage biopharmaceutical company developing
therapeutic solutions in ophthalmology, neurology, and oncology/hematology, today announced it has closed on a definitive securities
purchase agreement with a single institutional investor, acquiring $1.75 million worth of its common stock in a registered direct offering
(the &ldquo;Offering&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the terms of the
securities purchase agreement, the Company agreed to sell an aggregate of 500,000 shares of common stock and/or pre-funded warrants in
a registered direct offering. The purchase price per share of common stock is $3.50, and the purchase price for the pre-funded warrants
is identical to the purchase price for a share of common stock, less the exercise price of $0.01 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Wilmington Capital Securities,
LLC acted as the exclusive placement agent for the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross proceeds to the Company from the Offering
are estimated to be approximately $1.75 million before deducting the placement agent&rsquo;s fees and other offering expenses payable by the
Company. The Company will use the net proceeds from the Offering on research and development of their programs, working capital, and
other general corporate purposes, which may include the repayment of outstanding debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Offering of the shares of common stock and
pre-funded warrants described above was made by the Company pursuant to a &ldquo;shelf&rdquo; registration statement on Form S-3 (File
No. 333- 260588) initially filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on October 29, 2021, and declared effective
by the SEC on November 29, 2021, and the accompanying prospectus contained therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Offering is only
made by employing a prospectus supplement and accompanying prospectus. A prospectus supplement describing the terms of the Offering was filed with the SEC and is part of the effective registration statement.&nbsp;Copies of the prospectus supplement
relating to the registered direct offering, together with the accompanying prospectus, can be obtained at the SEC&rsquo;s website at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release does not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which
such offer, solicitation, or sale would be unlawful before registration or qualification under the securities laws of any such state
or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">We believe the Company&rsquo;s pipeline
products have great market potential. As per the Future Market Insights report, the MDD market was valued at $11.51 billion in 2022 and
is expected to reach $14.96 billion by 2032 with a CAGR of 2.8% over the forecast period.<SUP>1</SUP> According to the Polaris market
research report, the global ADHD treatment market was valued at $16.13 billion in 2022 and is expected to reach $32.14 billion by 2030
with a CAGR of 7.1% over the forecast period.<SUP>2</SUP> According to iHealthcare Analyst, Inc., the global market for retinal surgery
devices is expected to reach $3.7 billion by 2027, driven by the rising geriatric population worldwide.<SUP>3</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">###</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About ABVC BioPharma</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ABVC BioPharma is a clinical-stage biopharmaceutical
company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus<SUP>&reg;</SUP>) under development. For its drug
products, the Company utilizes in-licensed technology from its network of world-renowned research institutions to conduct proof-of-concept
trials through Phase II of clinical development. The Company&rsquo;s network of research institutions includes Stanford University, the University
of California at San Francisco, and Cedars-Sinai Medical Center. For Vitargus<SUP>&reg;</SUP>, the Company intends to conduct global
clinical trials through Phase III.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &ldquo;forward-looking
statements.&rdquo; Such statements may be preceded by the words &ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;plans,&rdquo;
&ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;projects,&rdquo; &ldquo;predicts,&rdquo; &ldquo;estimates,&rdquo; &ldquo;aims,&rdquo; &ldquo;believes,&rdquo;
&ldquo;hopes,&rdquo; &ldquo;potential,&rdquo; or similar words. Forward-looking statements are not guarantees of future performance, are
based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company&rsquo;s
control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied
by such forward-looking statements. None of the outcomes expressed herein are guaranteed. Such risks and uncertainties include, without
limitation, risks and uncertainties associated with (i) our inability to manufacture our product candidates on a commercial scale on
our own, or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes
in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory
approval to proceed to the next level of the clinical trials or to market our product candidates. More detailed information about the
Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company&rsquo;s filings with
the Securities and Exchange Commission (SEC), including the Company&rsquo;s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.
Investors are urged to read these documents free of charge on the SEC&rsquo;s website at&nbsp;http://www.sec.gov. The Company assumes no obligation
to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tom Masterson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: tmasterson@allelecomms.com</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">https://www.futuremarketinsights.com/reports/major-depressive-disorder-treatment-market#:~:text=The%20major%20depressive%20disorder%20(MDD,US%24%2011.51%20billion%20in%202022</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">https://www.prnewswire.com/news-releases/global-attention-deficit-hyperactivity-disorder-adhd-market-size-projected-to-reach-usd-32-14-billion-by-2032--with-cagr-of-7-1-study-by-polaris-market-research-301729196.html#:~:text=According%20to%20the%20research%20report</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">https://www.ihealthcareanalyst.com/technological-advancement-ophthalmic-surgery-retinal-surgery-devices-market/</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "& 8$# 2(  A$! Q$!_\0
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M?%WBC7;'Q]-8VNISQ6JS0J(EQ@ A<]O<U[%41DI-KL1&2DVNP4445984444
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M82AU ( 7)P3GL:]?HJ)14E9DRBI*S"BBBK*"BBB@ KG_  5_R*MO_P!=9_\
MT<]=!69H&FR:1HT5E-(DCH\C%DSCYI&8=?9J -.BBB@#R#Q=X3UZ^\=7&HVF
MF236IEB<.KH,A57/!(]#7I']MS_] +5/^^8O_BZUZ*A0LVUU(4+-M&1_;<__
M $ M4_[YB_\ BZT+2X:ZMQ*]M-;DDCRY@ P_(D?K4]%44%%%%,84444 %%%%
M !1110 4444P"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNY_+MEN')=FFD"CRLXY# ]/?WK7\4^4_B?PM!)*T>^XN 2CE67-NX!!'3D@
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JD98QP1K&I8Y. ,#-%% $]%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !# ' # 2(  A$! Q$!_\0
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M2M,L8KBTL]2UBWL)]>\4^((]4FN-2MK6QAMS^C?_ !#7_P#!+O\ Z$CXL?\
MAU]8_P#D*OC#_@C;^WM\.?V%/#/CO_@FS^W1J]K^SY\3?@G\0_%,G@WQ/XY5
MM'\&>*=$U[4/MDUB=>D06=E<27YN-;\/ZE>2+I7B+1-7A^Q7PN;![>7]\_\
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MO>)E%XHU-O\ A(_%&K&P.+^Z'V?3OLEJ?-/[G*+M^'_^(<#X'?\ 1Q_Q8_\
M"9\'_P#Q%3V__!N1\$+=RZ_M'?%=LKMPWACP=CKG/,9]!VKIXJR+P:P7#F<8
MOA'CKBG.^)J&#E4R7*<RX:IY=@,?C55P\8X?%XZ*YL+2=&>)FZJU4J5./VSX
MY<7?2BNK^$7A\EUMQW7O_P"E&UXL_8K_ .#>[QQXH\1^,_%&I? #5/$?BS7M
M7\3:]J#_ +1GBJ$WVM:[?SZEJEY]GM_B'%;6_P!IO;B:8PVT,4$>[9%&B*JC
MGO\ A@+_ (-T000_[/H((((_:0\8 @CD<CXC5J?\0ZGP2_Z.*^*G_A,>#?\
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=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>abvc-20230731.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaeKeaPtyJ1xSYkxuG9xfdkaXycp5QA2KitGQwIm8VcG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ABVC="http://abvcpharma.com/20230731" elementFormDefault="qualified" targetNamespace="http://abvcpharma.com/20230731">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abvcpharma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abvc-20230731_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abvc-20230731_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>abvc-20230731_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>abvc-20230731_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abvcpharma.com/role/Cover" xlink:href="abvc-20230731.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abvcpharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140505008738000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-91436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABVC BIOPHARMA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001173313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-0014658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">44370 Old Warm Springs Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fremont<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">668-0881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABVC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>ea182578-8k_abvcbio_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abvc-20230731.xsd" xlink:type="simple"/>
    <context id="AsOf2023-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173313</identifier>
        </entity>
        <period>
            <startDate>2023-07-31</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-07-31">0001173313</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-07-31">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-07-31">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-07-31">2023-07-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-07-31">ABVC BIOPHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-07-31">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-07-31">333-91436</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-07-31">26-0014658</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-07-31">44370 Old Warm Springs Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-07-31">Fremont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-07-31">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-07-31">94538</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-07-31">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-07-31">668-0881</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-07-31">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-07-31">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-07-31">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-07-31">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2023-07-31">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-07-31">ABVC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-07-31">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-07-31">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MTUH<KCF#N6 ?@/M+*<W'B=VYEO]X&/X+4$L#!!0    ( -1+_U:?H!OPL0(
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( -1+_U8'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ U$O_5KH0
M1MCN    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ U$O_5IE<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #42_]6,4*@!U $  "$
M$   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ U$O_5I^@&_"Q @  X@P   T              ( !DPP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #42_]6EXJ[',     3 @  "P
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52P4&      D "0 ^ @  YQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea182578-8k_abvcbio.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abvcpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea182578-8k_abvcbio.htm">ea182578-8k_abvcbio.htm</File>
    <File>abvc-20230731.xsd</File>
    <File>abvc-20230731_lab.xml</File>
    <File>abvc-20230731_pre.xml</File>
    <File>ea182578ex5-1_abvcbio.htm</File>
    <File>ea182578ex99-1_abvcbio.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea182578-8k_abvcbio.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea182578-8k_abvcbio.htm"
     ]
    },
    "labelLink": {
     "local": [
      "abvc-20230731_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abvc-20230731_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "abvc-20230731.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ABVC",
   "nsuri": "http://abvcpharma.com/20230731",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea182578-8k_abvcbio.htm",
      "contextRef": "AsOf2023-07-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://abvcpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea182578-8k_abvcbio.htm",
      "contextRef": "AsOf2023-07-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://abvcpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-23-061038-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-061038-xbrl.zip
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M7+$RUC3(?KW1/*ZTSBL[I'Y137R<*=VJC2GH-!*-@F].B274(I;!),R>9*(
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M9727$'ZV&J\1#1D_T"L6N6ZGYJU_*TA!VZ<@Y%LW-RH\'54QZ<0[P;:#@FN
M&')J/49$0^*\<<,.[N_GZDS(Y6F"&KBM-6^2_F'VY9H!M\  &W3BLW?J[S8W
MN,/CE43: R/0PV*%1*T^Z3)8?C0A."CWQ3=!LUXH]=8L,L#&0& '>97,5\2/
M*1#,--IS#/R8#D9-/"8*[S; 7QPJ2J)K!V']\0GJTF%8E_YABWJ)%M@]@XS\
M@^7%HA'X53?N!=-#-=<<\9.Y##KH;@G9<H]QN:H%;1UG F--#PI6FM$?\S(2
MMVN+2XLQ'+;Z=SB#MS>QT;4@E@,_. 60$H20(C*$/-(=D!' Y6@J'74=M F*
MS@D.V3)XY+DR[S[C[$!!@"H P?TD)PUQ1]+W:3S1DP6D%6X:82Z]N9%.""*Y
MT@(!=YMK+6Z$/S@*A (S^QFZV6.\UAN^?DN'[>71CLEFM4\%_.2L $$[X.S<
M ^Z!T"88TWAQSJ<1J%E%S2NT%'&>A]/2\,S+NG[4B_9>M=KQ!K/!MPSYQ/[I
MQVE>=H;N^:*GAQZO+S]K3SP>8[RXZEL<4E]>=$#D"0*%52@\8)9D*@9_A\!Z
MEQ2C3G>8O<Z6*&1VQ'1A1\QFMP.,?H:D3"+U:UO^*Q[,VZ.D/_^2:O]=IA6(
MMR!ZMY),[E$S*5.;)KWWFB;Q%:=B*ET4<+\P)Z0R0I+15$',B!DVSL13_&7)
M'45/].U!S"T!@MN("+W(5GVID01?[DL.\,.//Y^H/$97%;?WDO2U5O3:+?ZL
MNHS9]UY&O@C9?(&-L_.+T# 4S;L\=>Q@995<4J<#A@7L.+[1UB1_TP%,^DQQ
MCT>\&L_6UX*4\)G5("4LTX- WNE7D6?;$BMJ!/+F,ZI$L?AQ.E$LSJ](DU\)
M;S&5X1H$-@]F;Z?[+?0@LSK+WN8-&+/[GA#;FGP7E=31BE"WQ', :N&^VF8+
MZSRR[-59,#)&<E!,Z_P;&0A^)0.1O3<#;K_9.SMF8N*_'.)3G.]:;==:W"4-
M'JU8)83KG;=X_ZUL=Y(:'OI15YKKXK'$59/6T"O_73[L$GP);(E43-I1)/];
M )!7%SIR(!7:V?9'\4,7_^ZZ__+]<MR=K!]=5"ZO6K7/_M: J;&8W[XU\6M)
M3'=[(^J-M*&Z<>",XD[4&2T9/8M$'=SKL@-%.*RD,6(!):ZOQMRYP_I4[1)O
MHXQ7K;P.6#MP<$N<@Z..W==-<!9OO?7UJ?/:Z. "@*%7_1H35T@1YXY,$#PQ
M\7HOM/%FG1.>R7O]MPBMUBV="_=[.7W/\&4N5HJ*49X&L#\I/5D.>.XBR',+
ME[22Y,JVZ0#<@JVHO[98T?%6Y,.GJ?K]**KV%=8%2^:_#JG!7X=D_A9O_OO$
M2,2W]L$?>KHT&#E^^/G1E58YB=_M5.;?'V8/U/**WR15V+_EYZCY6V0"WT#%
M3L:'=[)PVKNO?.O_3%;D\9UX??]HIPO._<E9O:ZPOCB9#*[EFCRP\\7CG)+N
MJ$>]'T?UGX]#K5$KU+X?55-7_9%X>)T].SAP'@;WK?;=Z*[^F.N?YUIGJG3B
M' Y[K99V=F4/Q>2/FM'X]D,^'TV4G%P[,;O7SL')CY-^XX(U&]IA]UOON'U3
MJ(GYF]%0,T[_^S ^31UV3JH/WYP?TO#*JM7-_\I7:K[1OKRXN![:@X=F9__2
MV#^M]_*-;^GQ4>UJE.DXA?O#PL7/ ^VA>U"0[R:M<UFDG4+ZXOK4Z-\,CFWG
M?G*<M+OY2O6DV/ZN?W59\O]02P,$%     @ U$O_5BJNQ@J3%   -5\  !D
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M&E2_$?#3#N_[,LL-.[D#TYP*4U-XTK3GAC1G3?=UYLY/FZX[/=\K#<%>UBS
M#G)H:?T.]!VG=F5XL;8>$7%6LBFA#YYZ&3YU!:&3[VHQ6*\"H:U9O[;\'4W@
M#?.%$/NW-H^S;%PIQIZ.WX M+.KCJYF8Y3D[BXS\=2 H=A>T*1;X@%U,HCTR
MO"H9+'7ADK86^;58L<@!59A)MLN TXOK.14;&-TH<$O+FE(G*\],(*3K"C0G
M_$"@/(=]^S+@C:1$ZXG]*6R6D.Y3#Q*[U@%#ASJF-6P=DHIM#+3A3U@!+RS:
M8U?G*&<GP X\"ISP&M:'4-+*QA,GG5*QOGBE+&^.C?0*YN-/JFKB=;.1_2.(
MHGXGP9LX? Y.E.:K,1]PS69+\J#\FX%_/K7D-)4OQAY-%A]Y6$IPO779JZLF
MT:Z0Y"P@4%JGA(J1<BL97[!R(B(4X4CB(T!7-O2HC3CLG'2&T.< //P35SXZ
M!PNG:)+C4;IYH?.4N;7HOXW")"9$&G!0UBG_4+.ZN97RLKIDL<UR,)31=C*E
M.)AP&<'*Q+/$T=Z9&\>G=A^JR^JR40+IIW1G5,\)^W%THX=Z=P0GR8JLBLY]
M>,)!RJ+K+9&;.+ XQ4*LZR#O2M4,J\6RD#'E1A &YURXAA-HP+3EZ6K*!G63
M>CC*-CE5DT(-!SWIK<]CP*-W..O;E]Z<JY7PCLFFMNSU<+SL$X'XC"6&CF @
M7R9((@/MT ?D3@)OW1RNS^5')=:R997Q*>:5Y$R2:=E=>+56HF2P"P+RUB<W
M]HVGU2PGW;# "C:?/RK%NGZ@X!$V?2%+B3B<;-KM(>X9;YIG6"Z7.Q?5%$YW
M!8O9@<V+_\-AG.;_V[WZ)01@<R*BGX ?'HS%^84N$W&\4#N1>)[FL*.]'\2(
MY?AK7@+WO/H5\AWO[X,VSM6>O.9LV7>LAH/M_;W]^^+!P7BTO[\W;FY[+B_]
M/<+>LC_>'ST\>#3^[TTQ_]A,V>_WM]%(/-<J31Z+-W*F#K'H;[5"J,'>8C1R
MHU!'3U_^X@D+QVWV]LD<UB9NV$0F[(N;:R< O!_%WLX#L(,L3"<@X3-8O6IX
M:^,_/>38R2;P>[0++GH8H@CW<311Y"X>P[>0%,)%'_8L2HR'+#0Z*#HC39TM
M U'ODJRM>.^*!_KS35K])<[QC;'Q'N#2@3]71[:AU)6\I+%1VE94):!.?ZY#
MSW1S'08["-NV./+/3!.VYK*(::HM:S46FX( [!<$]K]_Y .ZZW&_50MMW"*$
M$L5VFR&\>ONNFQ-8A&. PEW]FH#/&HH6P!075568Q[N[%$B!;G88J>]DBYW:
M[&8E_S\:?_\(07:>[@P'[Q5C'1+77,TG)!1'Y EMX0!VY3J+CO!.#I)/*LF0
M+! S+Y+F,:$Q@&2CTAUD1":?4F7'="O_3;5_.+!-  )VM%^@)T?')PG=0L,.
MS%Y;!K*]4@U7EW%:&]>%=9(E*@#5.".69<+E-AT ?89Y'N*S4&QAS80E?5NF
M QRA<DX<JZ+B(@27US4!8VZ<N$7E0F(#BSB1F/QA(.^;5UECXT2R@7)!S1:D
M)Q^":9< H7>*AM[PVG:=-7%DQ15ED.$4#64$?Y61ISO/QO:>2[JI 4E=V,YP
MTX:2HR_EMM%D4\=D256I3F_%EQ4XE44.:1N30>_4Y>-56Z*Q92$N \./T2)-
MK:SR\8![=RG7C9TMNJJ"[XAT&H#DMKA7Z3L7_8RZ8;"VSNX+ZA%[>]H%NK(5
M*>)?E>NU=J[ Z"DD%>R/JURM!.;./XY !=A&@'&NL=UR+A.JC]D:$E/8['.E
ML$?%)ZHK<.D)?\ # ]"W'1.^>;T8%_F"55--\EE[(5=<8V'Y<J66RXP"Z69-
ME0"$PY001P,3VA$MKQ)?^;0.(J:N:N)J99"/;6$US8@K->J3G (1EGFJ2QAD
M[OJS!3T&]2:NFN7#G*_L!CT>[%A1"Y=MPNVRN=.SZ_KT02VDOX'F-FKE.QPT
M B8#U<9'S;7E?K<M)/JZ0K8#PJ5;:__K$J.GVM(9^>WA8+T78U7@JH>K3>;1
M#!*QVIJ[G6#:.J&KJ!'%W3NE"8FT9ML8J!^$Z!K")J:VB<:;,C?@Y"^V-]$Q
MM_O1=>[1]V[6.UO#@6]2V!9-Q)7O%9C1B>N49",)A A/"(OYAHGN"!O;^]?%
MR*:[=_M1481!T>9<853DQFG3S4BZD9(OA*."[63FE2G"ICUZ;7AM0FO#!K(L
M+XP-@7.M$WU-N.EU4>&@Y7I/_Y;\_3:7HAN<<+7][<!RZ',[I%[?JN_O9U,/
MHZ/_8 8M;MI#?6$HX <YVOVU^53V3.0;*TVYG(,AM-9$VV9HCB1MUF9^'1?>
M7]X/.D7]85&7;7>+TL+'9/H4+&S#WB^J4XHA<[DBUYDB#CH]3F3VL:R+*F:4
M8_)TH3+Z'899SF36=/#:X&F34SM$0],6.!>))I?NO+U]0\[0\!SEU:GMF6 K
M=T%0EZ1R-J&S6!?4Z]RFN>,R2=VH'<XP1YHU^K5I8H_-B2795:R4'0TBF$:+
MVYY-Y734S Z)2>VBG>.?)@9:$OBJ-T670MMM*6K#=@E@4LRBF;OFU.OL ^ G
M P^N 4Q=]QITDCJ8&QQJG'A):Y%DI<DSXI\&D"+;+I]*VX[CW^Q$+R@Y)"]
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MG2WOAC]1YG7/<"WZ?5/XP1/]+NK?4$L! A0#%     @ U$O_5K%]I;$J P
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M-S@M.&M?86)V8V)I;RYH=&U02P$"% ,4    " #42_]6*J[&"I,4   U7P
M&0              @ $B*P  96$Q.#(U-SAE>#4M,5]A8G9C8FEO+FAT;5!+
M 0(4 Q0    ( -1+_U:C(ER9*@X  !XU   :              "  >P_  !E
M83$X,C4W.&5X.3DM,5]A8G9C8FEO+FAT;5!+!08     !@ & )D!  !.3@
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
